Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘22 |
|
|---|---|---|---|---|---|
| $2.94M | $4.35M | $1.41M | 54.1% |
|
|
| $2.94M | $3.32M | $373K | 9.41% |
|
|
| $2.92M | $9.5M | $6.57M | 27.7% |
|
|
254
ARS Pharmaceuticals
SPRY
$993M
| $2.88M | $3.81M | $933K | 90.3% |
|
| $2.87M | $3.17M | $304K | 41.4% |
|
|
| $2.85M | $3.25M | $401K | 53.8% |
|
|
| $2.83M | $6.34M | $3.5M | 52.7% |
|
|
| $2.82M | $3.35M | $531K | 28.2% |
|
|
| $2.81M | $3.45M | $631K | 370% |
|
|
| $2.77M | $4.07M | $1.3M | 4.64% |
|
|
261
Replimune Group
REPL
$351M
| $2.75M | $2.75M | $0 | 73.9% |
|
| $2.69M | $2.69M | $0 | 20% |
|
|
| $2.68M | $5.01M | $2.33M | 23.5% |
|
|
| $2.64M | $4.08M | $1.44M | 19.4% |
|
|
| $2.62M | $3.04M | $427K | 71.4% |
|
|
| $2.61M | $6.33M | $3.72M | 51.2% |
|
|
| $2.6M | $3.78M | $1.18M | 50.2% |
|
|
| $2.55M | $2.56M | $10K | 122% |
|
|
| $2.52M | $4.16M | $1.63M | 93.6% |
|
|
| $2.51M | $4.18M | $1.67M | 27.6% |
|
|
| $2.49M | $3.95M | $1.46M | 5.95% |
|
|
| $2.47M | $3.09M | $620K | 3% |
|
|
| $2.47M | $11.7M | $9.24M | 60.2% |
|
|
| $2.46M | $5.34M | $2.89M | 28.6% |
|
|
| $2.43M | $3.83M | $1.4M | 31.6% |
|